SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare is trending as it approaches NASDAQ compliance, removing a significant delisting risk and intensifying community speculation for imminent End-of-Phase 2 results for its Fast Track-designated obstructive sleep apnea drug. Discussion highlights the stock's currently low market capitalization relative to its cash and pipeline, with many anticipating substantial upward movement given the newly tightened share float.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after reporting robust quarterly earnings, including beats on revenue and EPS, achieving full-year GAAP profitability, and announcing a significant new share buyback, which sparked a perplexing after-hours dip. The community is actively debating whether this decline is market manipulation or an exceptional buying opportunity, particularly given the company's strategic pivot into Agentic AI and discussions around potential government contracts.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending after achieving a successful and flawless launch of its Alpha rocket, a key event that has ignited widespread community excitement and renewed investor confidence. This successful mission, following prior delays, is driving discussions about the company's potential within the expanding space and defense sectors.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after reporting its first-ever quarterly operating profit, along with strong delivery guidance and news of its in-house AI chip entering mass production. The community is split between bullish excitement over this 'historic turnaround' and potential short squeeze, versus skepticism about sustained profitability amid persistent claims of market manipulation.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending following its recent Q4 report, which showcased significant revenue growth and an increased outlook, further bolstered by a new White Castle partnership for Uber Eats deliveries and an acquisition expanding its reach into healthcare. Community sentiment is mixed, with discussions focusing on the company's long-term potential in physical AI, Nvidia's support, and its expanding market presence versus ongoing valuation debates.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

CHAC is trending as its merger with Xanadu Quantum Technologies nears a shareholder vote, propelled by recent announcements of significant potential government support and new strategic partnerships with major tech and research entities, which the community sees as strong validation for Xanadu's photonic quantum computing leadership.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as escalating attacks disrupt shipping in the Strait of Hormuz, driving crude oil prices higher despite a historic 400 million barrel global reserve release, fueling a sharp debate among investors on whether prices will continue to surge or eventually crash.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

Caesars Entertainment is trending as reports surface of billionaire Tilman Fertitta in exclusive talks to acquire the company for approximately $34 per share, potentially igniting a bidding war against a rival offer from Carl Icahn. The community is sharply divided, with many shareholders expressing frustration over the proposed price and critically assessing management's role given the stock's historical highs.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is actively discussed due to recent label expansions for its oncology drug Libtayo and promising gene therapy data for hearing loss, bolstering its diverse pipeline, even as persistent manufacturing issues delay a key Eylea HD pre-filled syringe and intensify market competition in ophthalmology.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is trending after announcing overwhelmingly positive Phase 3 trial results for its kidney disease drug, povetacicept, which achieved a significant reduction in proteinuria. The community is highly optimistic about its potential as a breakthrough, anticipating accelerated FDA approval via a priority review voucher and its pivotal role in diversifying Vertex's strong portfolio beyond cystic fibrosis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


niuniubetorg

⚡ niuniubet